ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of July 5, 2026, ZTS trades at $74.80 with a market cap of $31.36B and a P/E ratio of 12.38. ZTS moved +4.33% today. Year to date, ZTS is -40.83%; over the trailing twelve months it is -52.98%. Its 52-week range spans $71.47 to $181.85. Analyst consensus is buy with an average price target of $114.14. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ZTS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $74.80 |
| Market Cap | $31.36B |
| P/E Ratio | 12.38 |
| EPS | $6.04 |
| Dividend Yield | 0.53% |
| 52-Week High | $181.85 |
| 52-Week Low | $71.47 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $9.51B |
| Net Income | $2.64B |
| Gross Margin | 71.76% |
10 analysts cover ZTS: 0 strong buy, 5 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $114.14.